Aeterna Zentaris Inc. Announces Name Change To COSCIENS Biopharma Inc. To Begin Trading Under The Trading Symbol "CSCI" August 9, 2024
Aeterna Zentaris Inc. Announces Name Change To COSCIENS Biopharma Inc. To Begin Trading Under The Trading Symbol "CSCI" August 9, 2024
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ:AEZS) (TSX:AEZS) ("COSCIENS" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries, today announces that the Company's name has been changed from "Aeterna Zentaris Inc." to "COSCIENS Biopharma Inc.", effective as of August 6, 2024 (the "Name Change").
COSCIENS Biopharma公司（原名Aeterna Zentaris公司）（NASDAQ:AEZS）（TSX:AEZS）（“COSCIENS”或“公司”）是一家专业的生物医药公司，致力于开发和商业化多元化的药品、诊断产品和医疗和化妆品行业的活性成分组合，并于今天宣布，公司名称由“Aeterna Zentaris公司”更名为“COSCIENS Biopharma公司”，并自2024年8月6日（“名称更改”）起生效。
In addition, the Company announces that, effective as of August 9, 2024, the Company's common shares (the "Common Shares") will begin trading on the Toronto Stock Exchange (the "TSX") and NASDAQ Capital Market (the "NASDAQ") under the trading symbol "CSCI" and will concurrently cease trading thereon under the former trading symbol "AEZS".
此外，公司宣布，自2024年8月9日起，公司的普通股（“普通股”）将在多伦多证券交易所（“TSX”）和纳斯达克资本市场（“纳斯达克”）上开始交易，交易符号为“CSCI”，同时将停止使用原有的交易符号“AEZS”.
